Advances in the Treatment of Schizophrenia: New Therapies and Management Strategies

Abstract

This article aims to review the most recent advances in the treatment of schizophrenia, exploring new therapies and management strategies, using the PubMed database with the terms "Schizophrenia", "Treatment", "Antipsychotics". In summary, recent advances in the treatment of schizophrenia have provided new hope for the management of this complex and challenging condition. The introduction of second-generation antipsychotics and the development of therapies targeting neurotransmitters other than dopamine have improved treatment efficacy and reduced side effects. In addition, the incorporation of new approaches such as cannabinoids, neurostimulation and immunological therapies opens new perspectives for treating refractory symptoms and improving the quality of life of patients. These innovations reflect significant progress in our understanding and management of schizophrenia. However, there are still challenges to be faced, including the need to optimize new therapies and identify personalized approaches for each patient. Combining drug therapies with psychosocial interventions and new monitoring technologies may offer a more comprehensive and effective treatment. Continued research is crucial to improve therapeutic strategies and address existing gaps, ensuring that advances translate into real benefits for patients with schizophrenia.